Key facts
- It has raised $1.7M; the latest was Angel (individual) ($630K) in May 2025.
- Notable investors include InnoFounder, Aage & Yelva Nimbs Foundation, Anders Borring, DTU Entrepreneurship, Danish Tech Challenge — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Uvisa
- ·The full record, as it builds
Funding rounds
No funding rounds for Uvisa are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Uvisa
Developer of a medical device and digital health platform designed to provide a drug-free approach to infection care. The company offers a light-based technology that targets microbes responsible for vaginal discomfort, enabling women to manage their health independently and reduce reliance on conventional antimicrobial treatments.
- Sector
- Healthcare
- HQ
- Copenhagen, Denmark
- Founded
- 2021
- Employees
- 10
- Website
- uvisahealth.com/
- Ownership
- Privately Held (backing)
Uvisa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Uvisa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Uvisa in its N-PORT filings yet. We sweep new filings monthly.